Fe Absorption in Mother and Child Pairs From Wheat Fortified With Iron With and Without Phenolic Containing Beverages

NCT ID: NCT02437955

Last Updated: 2015-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Senegal, iron deficiency affects 39% of and 82% of women and children between 12 and 50 months indicating that iron deficiency is a major health problem. The government of Senegal has implemented a flour fortification program including iron and folate. Iron is a difficult mineral to add to foods efficiently due to its organoleptic properties and typical low bioavailability in man. The aim of this study is to determine iron absorption from fortified wheat flour consumed with a phenolic containing beverage in women and child pairs. The fortificants used will be Ferrous Fumarate and Ferrous Sulfate, and the effect of absorption inhibitors on the bioavailability from iron compounds not readily bioavailable is poorly investigated.

The bioavailability of the different iron compounds will be determined using stable iron isotopes. Sixteen pairs of women and children (n=34, children between 3-6 years, women between 18-45y) will be selected for participation in the study. After a screening, each women and child will receive 4 test meals consisting of a bread roll fortified stable isotopes with and without the tisane beverage. The first two test meals will be consumed on consecutive days. Two weeks after the second test meal a blood sample will be taken from each women and child before the third meal administration. After the forth test meal administration, and again two weeks later, the last blood sampling will take place and the study will be conducted for the subjects (duration 30 days). The samples will be sent to Zurich on dry ice for analysis for the following parameters: isotopic composition, H pylori infection, B vitamin status, Vitamin A status. In all samples, hemoglobin and iron status as well as inflammation status (CRP) will be determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study each subject will act as his own control and receive all interventions. Iron absorption data from the different test meals will be therefore compared assessing within and subject effects (main outcomes). Secondary outcomes will also investigate between subject effects and co variates of iron absorption.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anemia; Deficiency, Nutritional, With Poor Iron Absorption

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FESO4+T

Ferrous sulfate fortified bread with tea

Group Type EXPERIMENTAL

Ferrous sulfate fortified bread with tea

Intervention Type OTHER

Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes

FESO4+W

Ferrous sulfate fortified bread with water

Group Type EXPERIMENTAL

ferrous sulfate fortified bread with water

Intervention Type OTHER

Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes

FeFu+T

Ferrous fumarate fortified bread with tea

Group Type EXPERIMENTAL

Ferrous fumarate fortified bread with tea

Intervention Type OTHER

Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes

FeFu+W

Ferrous fumarate fortified bread with water

Group Type EXPERIMENTAL

Ferrous fumarate fortified bread with water

Intervention Type OTHER

Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ferrous sulfate fortified bread with tea

Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes

Intervention Type OTHER

ferrous sulfate fortified bread with water

Fasting subjects will be served a wheat roll fortified with labelled ferrous sulfate and stable isotopes

Intervention Type OTHER

Ferrous fumarate fortified bread with tea

Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes

Intervention Type OTHER

Ferrous fumarate fortified bread with water

Fasting subjects will be served a wheat roll fortified with labelled Fe Fumarate and stable isotopes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mother and child are willing to participate in the study jointly

Specific inclusions criteria for mothers

* Body weight \< 65 kg
* 17 ≤ BMI ≤ 25 (kg/m2)
* Non anemic (Hb ≥ 11,0 g/dl)
* Generally healthy and no chronic illnesses
* Non pregnant
* Non lactating
* No blood donation in the last 4 months
* No consumption of vitamin and nutritional supplements during and 2 weeks prior the study start.


* Age 3-6 years
* Generally healthy and no chronic illnesses
* no consumption of vitamin and mineral supplements during and 2 weeks prior the study start
Minimum Eligible Age

3 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cheikh Anta Diop University, Senegal

OTHER

Sponsor Role collaborator

Swiss Federal Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ndeye Fatou Ndiaye, PhD

Role: PRINCIPAL_INVESTIGATOR

Université Cheikh Anta Diop de Dakar, Sengal

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Université Cheikh Anta Diop

Dakar, , Senegal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Senegal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 2014-N-37

Identifier Type: -

Identifier Source: org_study_id